Malaria is a serious but rare disease caused by bites from infected mosquitos. Now the drug is used to treat inflammatory diseases. Hydroxychloroquine high Plaquenil pulmonary toxicity Hydroxychloroquine is a well-tolerated medication for various rheumatologic and dermatologic conditions. Its main side effects are gastrointestinal upset, skin rash, headache, and ocular toxicity1. Within the eye, hydroxychloroquine can adversely impact the cornea, ciliary body, and retina1 Plaquenil Hydroxychloroquine sulfate is a drug originally used to prevent or treat malaria. Malaria is a serious but rare disease caused by bites from infected mosquitos. Now the drug is used to treat inflammatory diseases. Ophthalmology. 2017 Mar;1243e29-e30. BACKGROUND The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. Some diseases treated with Plaquenil include: Plaquenil lowers your immune system’s ability to cause inflammation. This type of disease occurs when the body's immune system attacks its own healthy tissue. American academy of ophthalmology hydroxychloroquine screening Despite Plaquenil dosing recommendations, retinal toxicity remains, What Is Plaquenil? - American Academy of Ophthalmology Hydroxychloroquine and chloroquine retinopathy Aug 30, 2011 Screening Guidelines. The American Academy of Ophthalmology AAO has recently provided revised recommendations for screening that incorporates new advances in technology allowing for earlier detection of the disease in 2016. Hydroxychloroquine Plaquenil Toxicity and Recommendations.. Recommendations on Screening for Chloroquine and.. Revised recommendations on screening for chloroquine and.. A recent article published by the American Academy of Ophthalmology AAO presented new recommendations for screening of patients being managed with hydroxychloroquine HCQ. In this article, new recommendations were made that changed the previous monitoring paradigm. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF. American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;1182415-42221292109PubMed Google Scholar Crossref NEW SCREENING GUIDELINES. A task force of the American Academy of Ophthalmology published screening guidelines in 2002. However, new data indicate that the incidence of hydroxychloroquine toxicity may be higher than previously thought.